855303-RNA Biomarker Validation

Part of paid clinical trials in Sacramento, California.

Sponsor
University of Pennsylvania
Study ID
NCT06872775
Status
Enrolling By Invitation

Conditions

  • Fractures, Bone

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blood draws to assess RNA expression levels — OTHER
    None. Standard of Care (SOC) only.

Study Details

The purpose of this study is to test the accuracy of using RNA in blood as a way to forecast new fracture healing outcome.

Key Dates

Start date
Aug 25, 2025
Status verified
Jan 2026
Primary completion
Aug 24, 2028
Completion
Aug 24, 2028

Study Design

Enrollment
110 participants (estimated)

Arms

  • Arm: New Traumatic Fractures
    Anyone age 18 or over presenting to participating sites for care of new, traumatic appendicular fractures.

Primary Outcome Measure

Proportion of subjects with correct predicted outcome [ Time Frame: 0 - 270 days ]

Locations (7)

FacilityCityStateZIPSite coordinators
University of California, Davis Medical CenterSacramentoCalifornia95817-
Indiana UniversityBloomingtonIndiana47401-3654-
University of MissouriColumbiaMissouri65211-0001-
Wake Forest University Health Sciences/Advocate HealthCharlotteNorth Carolina28203-
University of PennsylvaniaPhiladelphiaPennsylvania19104-
Vanderbilt University Medical CenterNashvilleTennessee37232-
University of Texas Health Science Center at HoustonHoustonTexas77030-5400-

Find similar trials in Sacramento, CA

By research site
University of California, Davis Medical Center· Sacramento, CAIndiana University· Bloomington, INUniversity of Missouri· Columbia, MOWake Forest University Health Sciences/Advocate Health· Charlotte, NCUniversity of Pennsylvania· Philadelphia, PAVanderbilt University Medical Center· Nashville, TN

Related Studies